Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Renal Failure

  Free Subscription


Articles published in Am J Nephrol

Retrieve available abstracts of 98 articles:
HTML format
Text format



Single Articles


    August 2017
  1. HARDING K, Mersha TB, Webb FA, Vassalotti JA, et al
    Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease.
    Am J Nephrol. 2017;46:156-164.
    PubMed     Text format     Abstract available


  2. HARDING K, Mersha TB, Vassalotti JA, Webb FA, et al
    Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans.
    Am J Nephrol. 2017;46:176-186.
    PubMed     Text format     Abstract available


    July 2017
  3. RIBEIRO SC, Figueiredo AE, Barretti P, Pecoits-Filho R, et al
    Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;46:150-155.
    PubMed     Text format     Abstract available


  4. HAMDI T, Palmer BF
    Review of Extracorporeal Membrane Oxygenation and Dialysis-Based Liver Support Devices for the Use of Nephrologists.
    Am J Nephrol. 2017;46:139-149.
    PubMed     Text format     Abstract available


  5. BRAR A, Mallappallil M, Stefanov DG, Kau D, et al
    Dialysis in the Elderly and Impact of Institutionalization in the United States Renal Data System.
    Am J Nephrol. 2017;46:114-119.
    PubMed     Text format     Abstract available


  6. KIM T, Streja E, Soohoo M, Rhee CM, et al
    Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.
    Am J Nephrol. 2017;46:120-130.
    PubMed     Text format     Abstract available


  7. ABE M, Hamano T, Wada A, Nakai S, et al
    High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.
    Am J Nephrol. 2017;46:82-92.
    PubMed     Text format     Abstract available


  8. AFSHINNIA F, Zeng L, Byun J, Gadegbeku CA, et al
    Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.
    Am J Nephrol. 2017;46:73-81.
    PubMed     Text format     Abstract available


    June 2017
  9. LIU W, Wang L, Wei Y, Li X, et al
    Interaction of Soluble CXC Ligand 16 and Cardiac Injury Markers in Hemodialysis Patients.
    Am J Nephrol. 2017;46:64-70.
    PubMed     Text format     Abstract available


  10. FERNANDES A, Ribera-Sanchez R, Rodriguez-Carmona A, Lopez-Iglesias A, et al
    Peritoneal Water Transport Characteristics of Diabetic Patients Undergoing Peritoneal Dialysis: A Longitudinal Study.
    Am J Nephrol. 2017;46:47-54.
    PubMed     Text format     Abstract available


  11. AVILA M, Mora C, Prado MDC, Zavala M, et al
    Osteoprotegerin Is the Strongest Predictor for Progression of Arterial Calcification in Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;46:39-46.
    PubMed     Text format     Abstract available


  12. LENHARD MJ, Maser RE
    Vascular Calcification and Osteoprotegrin in Chronic Kidney Disease.
    Am J Nephrol. 2017;46:37-38.
    PubMed     Text format    


  13. HASEGAWA T, Zhao J, Fuller DS, Bieber B, et al
    Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins.
    Am J Nephrol. 2017;46:11-17.
    PubMed     Text format     Abstract available


  14. UDO A, Goodlad C, Davenport A
    Impact of Diabetes on Extracellular Volume Status in Patients Initiating Peritoneal Dialysis.
    Am J Nephrol. 2017;46:18-25.
    PubMed     Text format     Abstract available


    May 2017
  15. HUSSEIN WF, Arramreddy R, Sun SJ, Reiterman M, et al
    Higher Ultrafiltration Rate Is Associated with Longer Dialysis Recovery Time in Patients Undergoing Conventional Hemodialysis.
    Am J Nephrol. 2017;46:3-10.
    PubMed     Text format     Abstract available


  16. PLANTINGA LC, Jaar BG
    On the Right Track: Implementing Interventions to Reduce Readmissions in Dialysis Patients.
    Am J Nephrol. 2017;45:549-551.
    PubMed     Text format    


  17. WANG C, Fu X, Yang Y, Deng J, et al
    A Comparison between Intermittent Peritoneal Dialysis and Automatic Peritoneal Dialysis on Urgent Peritoneal Dialysis.
    Am J Nephrol. 2017;45:540-548.
    PubMed     Text format     Abstract available


  18. WINGARD RL, McDougall K, Axley B, Howard A, et al
    Right TraC Post-Hospitalization Care Transitions Program to Reduce Readmissions for Hemodialysis Patients.
    Am J Nephrol. 2017;45:532-539.
    PubMed     Text format     Abstract available


  19. KIM T, Rhee CM, Streja E, Soohoo M, et al
    Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort.
    Am J Nephrol. 2017;45:509-521.
    PubMed     Text format     Abstract available


  20. LIU YT, Hung TY, Lee YK, Huang MY, et al
    Association between Chronic Kidney Disease and Risk of Cataract: A Nationwide Retrospective Cohort Study.
    Am J Nephrol. 2017;45:524-531.
    PubMed     Text format     Abstract available


  21. MACK HG, Savige J
    Chronic Kidney Disease and Cataract: Seeing the Light.
    Am J Nephrol. 2017;45:522-523.
    PubMed     Text format    


  22. RAIMANN JG, Barth C, Usvyat LA, Preciado P, et al
    Dialysis Access as an Area of Improvement in Elderly Incident Hemodialysis Patients: Results from a Cohort Study from the International Monitoring Dialysis Outcomes Initiative.
    Am J Nephrol. 2017;45:486-496.
    PubMed     Text format     Abstract available


  23. NEE R, Fisher E, Yuan CM, Agodoa LY, et al
    Pre-End-Stage Renal Disease Care and Early Survival among Incident Dialysis Patients in the US Military Health System.
    Am J Nephrol. 2017;45:464-472.
    PubMed     Text format     Abstract available


  24. YEE J, Campbell RC
    The Interdisciplinary Chronic Kidney Disease Clinic: End of the Beginning, Not Beginning of the End.
    Am J Nephrol. 2017;45:461-463.
    PubMed     Text format    


  25. ALSHAHAWEY M, Shahin SM, Elsaid TW, Sabri NA, et al
    Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
    Am J Nephrol. 2017;45:452-459.
    PubMed     Text format     Abstract available


    April 2017
  26. BHANDARI SK, Liu IA, Kujubu DA, Huynh T, et al
    Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes.
    Am J Nephrol. 2017;45:431-441.
    PubMed     Text format     Abstract available


  27. FLYTHE JE, Hilbert J, Kshirsagar AV, Gilet CA, et al
    Psychosocial Factors and 30-Day Hospital Readmission among Individuals Receiving Maintenance Dialysis: A Prospective Study.
    Am J Nephrol. 2017;45:400-408.
    PubMed     Text format     Abstract available


    March 2017
  28. MARTIN ER, Smith MT, Maroni BJ, Zuraw QC, et al
    Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease.
    Am J Nephrol. 2017;45:380-388.
    PubMed     Text format     Abstract available


  29. HAMMES M
    When Is the Right Time for Arteriovenous Fistula Placement in Patients with End-Stage Renal Disease?
    Am J Nephrol. 2017;45:353-355.
    PubMed     Text format    


  30. MIYAMOTO M, Kurita N, Suemitsu K, Murakami M, et al
    Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients.
    Am J Nephrol. 2017;45:356-364.
    PubMed     Text format     Abstract available


  31. YI C, Guo Q, Lin J, Li J, et al
    Patient-Doctor Contact Interval and Clinical Outcomes in Continuous Ambulatory Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;45:346-352.
    PubMed     Text format     Abstract available


  32. ILORI TO, Wang X, Huang M, Gutierrez OM, et al
    Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease.
    Am J Nephrol. 2017;45:338-345.
    PubMed     Text format     Abstract available


    February 2017
  33. BARAGETTI I, El Essawy B, Fiorina P
    Targeting Immunity in End-Stage Renal Disease.
    Am J Nephrol. 2017;45:310-319.
    PubMed     Text format     Abstract available


  34. FAN Q, Yan Y, Gu L, He L, et al
    Prognostic Value of the Delivery Dialysis Dose on Twice-Weekly Hemodialysis Patients.
    Am J Nephrol. 2017;45:273-282.
    PubMed     Text format     Abstract available


  35. LANGSFORD D, Tang M, Cheikh Hassan HI, Djurdjev O, et al
    The Association between Biomarker Profiles, Etiology of Chronic Kidney Disease, and Mortality.
    Am J Nephrol. 2017;45:226-234.
    PubMed     Text format     Abstract available


    January 2017
  36. WONG LL, Kalantar-Zadeh K, Page V, Hayashida G, et al
    Insights from Screening a Racially and Ethnically Diverse Population for Chronic Kidney Disease.
    Am J Nephrol. 2017;45:200-208.
    PubMed     Text format     Abstract available


  37. LOCATELLI F, Fishbane S, Block GA, Macdougall IC, et al
    Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients.
    Am J Nephrol. 2017;45:187-199.
    PubMed     Text format     Abstract available


  38. BRAR A, Markell M, Stefanov DG, Timpo E, et al
    Mortality after Renal Allograft Failure and Return to Dialysis.
    Am J Nephrol. 2017;45:180-186.
    PubMed     Text format     Abstract available


  39. WOLFGRAM DF, Garcia K, Evans G, Zamanian S, et al
    Association of Albuminuria and Estimated Glomerular Filtration Rate with Functional Performance Measures in Older Adults with Chronic Kidney Disease.
    Am J Nephrol. 2017;45:172-179.
    PubMed     Text format     Abstract available


  40. ABAD S, Vega A, Hernandez E, Merida E, et al
    Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.
    Am J Nephrol. 2017;45:267-272.
    PubMed     Text format     Abstract available


  41. VADUGANATHAN M, Bhatt DL
    Cardiac Troponins in Chronic Kidney Disease: A Marker of Global Cardiovascular Risk.
    Am J Nephrol. 2017;45:301-303.
    PubMed     Text format    


  42. SHARMA K
    Myeloperoxidase Activity and Oxidized Amino Acids as Biomarkers in Chronic Kidney Disease and Coronary Artery Disease.
    Am J Nephrol. 2017;46:71-72.
    PubMed     Text format    


    December 2016
  43. XUE C, Yang B, Zhou C, Dai B, et al
    Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;45:149-159.
    PubMed     Text format     Abstract available


  44. FILLER G, McIntyre C
    Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?
    Am J Nephrol. 2016;45:146-148.
    PubMed     Text format    


  45. AKIZAWA T, Tsubakihara Y, Nangaku M, Endo Y, et al
    Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects.
    Am J Nephrol. 2016;45:127-135.
    PubMed     Text format     Abstract available


  46. REQUE J, Garcia-Prieto A, Linares T, Vega A, et al
    Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;45:107-114.
    PubMed     Text format     Abstract available


    November 2016
  47. FERREIRA JP, Girerd N, Pannier B, Rossignol P, et al
    High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60.
    Am J Nephrol. 2016;45:72-81.
    PubMed     Text format     Abstract available


  48. ZOCCALI C, Mallamaci F
    Arterial Stiffness as a Cardiovascular Risk Factor in Stage 5D Chronic Kidney Disease Patients: An Age Affair.
    Am J Nephrol. 2016;45:69-71.
    PubMed     Text format    


  49. DE SOUZA VC, Rabilloud M, Cochat P, Wagner MB, et al
    Trajectories and Predictors of Allograft Dysfunction after Renal Transplantation in Children.
    Am J Nephrol. 2016;45:63-68.
    PubMed     Text format     Abstract available


  50. THADHANI R, Zella JB, Knutson DC, Blaser WJ, et al
    2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial.
    Am J Nephrol. 2016;45:40-48.
    PubMed     Text format     Abstract available


  51. CHOI Y, Shin J, Park JT, Cho KH, et al
    Disparities in Kidney Transplantation Access among Korean Patients Initiating Dialysis: A Population-Based Cohort Study Using National Health Insurance Data (2003-2013).
    Am J Nephrol. 2016;45:32-39.
    PubMed     Text format     Abstract available


  52. MCCABE KM, Booth SL, Fu X, Ward E, et al
    Vitamin K Metabolism in a Rat Model of Chronic Kidney Disease.
    Am J Nephrol. 2016;45:4-13.
    PubMed     Text format     Abstract available


  53. GALE RC, Kehoe D, Lit YZ, Asch SM, et al
    Effect of a Dialysis Access Coordinator on Preemptive Access Placement among Veterans: A Quality Improvement Initiative.
    Am J Nephrol. 2016;45:14-21.
    PubMed     Text format     Abstract available


  54. FUSARO M, Plebani M, Iervasi G, Gallieni M, et al
    Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up.
    Am J Nephrol. 2016;45:1-3.
    PubMed     Text format    


  55. SHARMA A, Yabes J, Al Mawed S, Wu C, et al
    Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients.
    Am J Nephrol. 2016;44:462-472.
    PubMed     Text format     Abstract available


  56. FOSTER R, Walker S, Brar R, Hiebert B, et al
    Cognitive Impairment in Advanced Chronic Kidney Disease: The Canadian Frailty Observation and Interventions Trial.
    Am J Nephrol. 2016;44:473-480.
    PubMed     Text format     Abstract available


    October 2016
  57. NOVICK T, Liu Y, Alvanzo A, Zonderman AB, et al
    Lifetime Cocaine and Opiate Use and Chronic Kidney Disease.
    Am J Nephrol. 2016;44:447-453.
    PubMed     Text format     Abstract available


  58. LANOT A, Lobbedez T, Bechade C, Verger C, et al
    Efficacy of Prophylactic Antibiotics at Peritoneal Catheter Insertion on Early Peritonitis: Data from the Catheter Section of the French Language Peritoneal Dialysis Registry.
    Am J Nephrol. 2016;44:419-425.
    PubMed     Text format     Abstract available


  59. CHEN TY, Lin TT, Hsieh MY, Lin L, et al
    Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas.
    Am J Nephrol. 2016;44:428-438.
    PubMed     Text format     Abstract available


  60. BUSHINSKY DA, Rossignol P, Spiegel DM, Benton WW, et al
    Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis.
    Am J Nephrol. 2016;44:404-410.
    PubMed     Text format     Abstract available


  61. MACLAUGHLIN HL, Macdougall IC, Hall WL, Dew T, et al
    Does Intragastric Balloon Treatment for Obesity in Chronic Kidney Disease Heighten Acute Kidney Injury Risk?
    Am J Nephrol. 2016;44:411-418.
    PubMed     Text format     Abstract available


  62. SAKURA M, Inaba M, Yoda K, Ichii M, et al
    High Coronary Heart Disease Risk in Hemodialysis Patients with Central Sleep Apnea: A Pilot Study.
    Am J Nephrol. 2016;44:388-395.
    PubMed     Text format     Abstract available


  63. CHADE AR, Hall JE
    Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.
    Am J Nephrol. 2016;44:354-367.
    PubMed     Text format     Abstract available


  64. SAKHUJA A, Wright RS, Schold JD, McCarthy JT, et al
    National Impact of Maintenance Dialysis or Renal Transplantation on Outcomes Following ST Elevation Myocardial Infarction.
    Am J Nephrol. 2016;44:329-338.
    PubMed     Text format     Abstract available


  65. BOLAD IA
    ST-Segment Elevation Myocardial Elevation in Dialysis and Renal Transplant Patients. How Does It Compare to That in the General Population?
    Am J Nephrol. 2016;44:327-328.
    PubMed     Text format    


    September 2016
  66. SPRAGUE SM, Crawford PW, Melnick JZ, Strugnell SA, et al
    Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
    Am J Nephrol. 2016;44:316-325.
    PubMed     Text format     Abstract available


  67. SMITH ZG, McNicoll L, Clark TL, Cohen AJ, et al
    Medical Neighborhood Model for the Care of Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;44:308-315.
    PubMed     Text format     Abstract available


  68. TRINH E, Chan CT
    Intensive Home Hemodialysis Results in Regression of Left Ventricular Hypertrophy and Better Clinical Outcomes.
    Am J Nephrol. 2016;44:300-307.
    PubMed     Text format     Abstract available


  69. WALLQUIST C, Mansouri L, Norrback M, Hylander B, et al
    Early Changes in Monocyte Adhesion Molecule Expression and Tumor Necrosis Factor-alpha Levels in Chronic Kidney Disease - A 5-Year Prospective Study.
    Am J Nephrol. 2016;44:268-275.
    PubMed     Text format     Abstract available


  70. GENOVESI S
    Oral Anticoagulation in End-Stage Renal Disease: Is It Time to Absolve Warfarin?
    Am J Nephrol. 2016;44:255-257.
    PubMed     Text format    


  71. BRANCACCIO D, Neri L, Bellocchio F, Barbieri C, et al
    Patients' Characteristics Affect the Survival Benefit of Warfarin Treatment for Hemodialysis Patients with Atrial Fibrillation. A Historical Cohort Study.
    Am J Nephrol. 2016;44:258-267.
    PubMed     Text format     Abstract available


  72. JIANG Y, Shen Z, Zhang J, Xing C, et al
    Parathyroidectomy Increases Heart Rate Variability and Leptin Levels in Patients with Stage 5 Chronic Kidney Disease.
    Am J Nephrol. 2016;44:245-254.
    PubMed     Text format     Abstract available


  73. YUSUF AA, Hu Y, Singh B, Menoyo JA, et al
    Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study.
    Am J Nephrol. 2016;44:179-186.
    PubMed     Text format     Abstract available


    August 2016
  74. SAKAO Y, Sugimoto M, Ichikawa H, Sahara S, et al
    Severity of Gastric Mucosal Atrophy Is the Major Determinant of Plasma Ghrelin Level in Hemodialysis Patients.
    Am J Nephrol. 2016;44:224-233.
    PubMed     Text format     Abstract available


  75. AL DHAYBI O, Bakris G
    New Onset Hypertension Linked to Generic Cyclosporine Substitution in Post-Renal Transplant Patient.
    Am J Nephrol. 2016;44:219-223.
    PubMed     Text format     Abstract available


  76. DIAS C, Moore KT, Murphy J, Ariyawansa J, et al
    Rivaroxaban in Chronic Hemodialysis Patients: Clarification of an Editorial Error.
    Am J Nephrol. 2016;44:169.
    PubMed     Text format    


  77. ROCCO MV, Chapman A, Chertow GM, Cohen D, et al
    Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.
    Am J Nephrol. 2016;44:130-140.
    PubMed     Text format     Abstract available


  78. ALICIC RZ, Short RA, Corbett CL, Neumiller JJ, et al
    Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics.
    Am J Nephrol. 2016;44:122-129.
    PubMed     Text format     Abstract available


    July 2016
  79. SPRAGUE SM, Covic AC, Floege J, Ketteler M, et al
    Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
    Am J Nephrol. 2016;44:104-112.
    PubMed     Text format     Abstract available


  80. NORRIS KC, Nicholas SB
    Racial Disparities in End-of-Life Issues in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;44:81-83.
    PubMed     Text format    


  81. KIM HJ, Lee H, Kim DK, Oh KH, et al
    Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients.
    Am J Nephrol. 2016;44:71-80.
    PubMed     Text format     Abstract available


  82. LEMOINE S, Panaye M, Pelletier C, Bon C, et al
    Cystatin C-Creatinine Based Glomerular Filtration Rate Equation in Obese Chronic Kidney Disease Patients: Impact of Deindexation and Gender.
    Am J Nephrol. 2016;44:63-70.
    PubMed     Text format     Abstract available


  83. LEEHEY DJ, Collins E, Kramer HJ, Cooper C, et al
    Structured Exercise in Obese Diabetic Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Am J Nephrol. 2016;44:54-62.
    PubMed     Text format     Abstract available


    June 2016
  84. CHAN D, Cheema BS
    Progressive Resistance Training in End-Stage Renal Disease: Systematic Review.
    Am J Nephrol. 2016;44:32-45.
    PubMed     Text format     Abstract available


  85. JOHANSEN KL
    Resistance Exercise in the Hemodialysis Population - Who Should Do the Heavy Lifting?
    Am J Nephrol. 2016;44:29-31.
    PubMed     Text format    


  86. ENEANYA ND, Wenger JB, Waite K, Crittenden S, et al
    Racial Disparities in End-of-Life Communication and Preferences among Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;44:46-53.
    PubMed     Text format     Abstract available


  87. TASEVSKA I, Enhorning S, Christensson A, Persson M, et al
    Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population.
    Am J Nephrol. 2016;44:22-28.
    PubMed     Text format     Abstract available


  88. SHIRAZIAN S, Diep R, Jacobson AM, Grant CD, et al
    Awareness of Chronic Kidney Disease and Depressive Symptoms: National Health and Nutrition Examination Surveys 2005-2010.
    Am J Nephrol. 2016;44:1-10.
    PubMed     Text format     Abstract available


    May 2016
  89. VASCO RF, Moyses RM, Zatz R, Elias RM, et al
    Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease.
    Am J Nephrol. 2016;43:421-430.
    PubMed     Text format     Abstract available


  90. WESSON DE
    Does an Acid-Milieu in Chronic Kidney Disease Contribute to Its Increased Cardiovascular Mortality?
    Am J Nephrol. 2016;43:408-410.
    PubMed     Text format    


  91. DOBRE M, Roy J, Tao K, Anderson AH, et al
    Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study.
    Am J Nephrol. 2016;43:411-420.
    PubMed     Text format     Abstract available


  92. RHEE EP, Clish CB, Wenger J, Roy J, et al
    Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.
    Am J Nephrol. 2016;43:366-374.
    PubMed     Text format     Abstract available


  93. LEE T, Thamer M, Zhang Q, Zhang Y, et al
    Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;43:334-340.
    PubMed     Text format     Abstract available


  94. CLARK WF, Sontrop JM, Huang SH, Moist L, et al
    Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence.
    Am J Nephrol. 2016;43:281-292.
    PubMed     Text format     Abstract available


    April 2016
  95. BROWN JR, Rezaee ME, Hisey WM, Cox KC, et al
    Reduced Mortality Associated with Acute Kidney Injury Requiring Dialysis in the United States.
    Am J Nephrol. 2016;43:261-270.
    PubMed     Text format     Abstract available


    January 2016
  96. SRINIVAS T
    Brain Imaging and Cognition after Kidney Transplantation.
    Am J Nephrol. 2016;43:47-9.
    PubMed     Text format    


    August 2015
  97. RUBIN MF, Weir MR
    Access to Kidney Transplantation: Is There a Potential Conflict of Interest?
    Am J Nephrol. 2015;41:502-503.
    PubMed     Text format    


    July 2015
  98. HUANG E, Bunnapradist S
    Pre-Transplant Weight Loss and Survival after Kidney Transplantation.
    Am J Nephrol. 2015;41:448-455.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: